PHARMACOECONOMICS ANALYSIS OF TREATMENT OF METASTATIC COLORECTAL CANCER WITH BEVACIZUMAB IN BRAZIL

被引：0
|
作者：
Tonon, L. M. [1 ]
Secoli, S. R. [2 ]
机构：
[1] Hosp Sirio Libanes, Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75350-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A497 / A497
页数：1
相关论文
共 50 条
  • [31] Visceral fat and bevacizumab in metastatic colorectal cancer
    Jubb, A. M.
    GUT, 2010, 59 (10) : 1449 - 1450
  • [32] Bevacizumab in the therapy for refractory metastatic colorectal cancer
    Mulcahy, Mary F.
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01): : 53 - 59
  • [33] Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
    Tol, Jolien
    Koopman, Miriam
    Cats, Annemieke
    Rodenburg, Cees J.
    Creemers, Geert J. M.
    Schrama, Jolanda G.
    Erdkamp, Frans L. G.
    Vos, Allert H.
    van Groeningen, Cees J.
    Sinnige, Harm A. M.
    Richel, Dirk J.
    Voest, Emile E.
    Dijkstra, Jeroen R.
    Vink-Borger, Marianne E.
    Antonini, Ninja F.
    Mol, Linda
    van Krieken, Johan H. J. M.
    Dalesio, Otilia
    Punt, Cornelis J. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (06): : 563 - 572
  • [34] Chemotherapy With Bevacizumab for Advanced or Metastatic Colorectal Cancer
    Hirata, Masaru
    GASTROENTEROLOGY, 2014, 146 (05) : S694 - S694
  • [35] SAFETY PROFILE OF BEVACIZUMAB IN METASTATIC COLORECTAL CANCER
    Castillo, M. A.
    Ubago, R.
    Flores, S.
    Rodriguez, R.
    Beltran, C.
    VALUE IN HEALTH, 2011, 14 (07) : A437 - A437
  • [36] BEVACIZUMAB IN METASTATIC COLORECTAL CANCER: MOROCCAN CHALLENGE
    Mouzount, H.
    Allam, W.
    Errihani, H.
    ANNALS OF ONCOLOGY, 2009, 20 : 73 - 73
  • [37] Bevacizumab Maintenance in Metastatic Colorectal Cancer Reply
    Aparicio, Thomas
    Ghiringhelli, Francois
    Boige, Valerie
    Le Malicot, Karine
    Taieb, Julien
    Bennouna, Jaafar
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (23) : 2452 - +
  • [38] Pharmacoeconomics of available treatment options for metastatic prostate cancer
    Zeliadt, Steven B.
    Penson, David F.
    PHARMACOECONOMICS, 2007, 25 (04) : 309 - 327
  • [39] Pharmacoeconomics of Available Treatment Options for Metastatic Prostate Cancer
    Steven B. Zeliadt
    David F. Penson
    PharmacoEconomics, 2007, 25 : 309 - 327
  • [40] Racial disparities in metastatic colorectal cancer outcomes revealed by tumor microbiome and transcriptome analysis with bevacizumab treatment
    Feng, Lei
    Wang, Rui
    Zhao, Qian
    Wang, Jun
    Luo, Gang
    Xu, Chongwen
    FRONTIERS IN PHARMACOLOGY, 2024, 14
12345